Observational Study on Levemir® in Obese Diabetic Patients
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to investigate the
effect of switch from other basal insulin treatments to Levemir® on body weight in obese
diabetic patients. A local extension will be conducted in Slovenia in order to reach the
planned 400 patients for the sub-analysis of Slovenian patients.
Included in the study is a retrospective part to evaluate the weight progress since
initiation of insulin treatment of another basal insulin and/or oral antidiabetic drugs (OAD)
and/or bolus insulin therapy. Retrospective data will be collected at baseline and at
approximately 6 and 12 months before starting insulin detemir therapy.